A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Gancyclovir Gel (Zirgan) Versus 0.3% Hypromellose Gel (Genteal Gel; Placebo) for the Treatment of Herpes Zoster Keratitis
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Ganciclovir (Primary) ; Hypromellose
- Indications Ocular herpes simplex
- Focus Therapeutic Use
- 13 Oct 2016 Planned End Date changed from 1 Jan 2017 to 1 Jan 2019.
- 13 Oct 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2018.
- 18 Mar 2015 New trial record